Skip to content
Study details
Enrolling now

MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Clinical Nutrition Research Center, Illinois Institute of Technology
NCT IDNCT06555952ClinicalTrials.gov data as of Apr 2026
Target enrollment

80

Study length

about 2.4 years

Ages

40–60

Locations

1 site in IL

What this study is about

Researchers are testing if taking MegaNatural BP, a Grape seed Extract (GSE) supplement, helps lower blood pressure and improve heart health. The trial will assess how well the supplement affects inflammation and blood vessel function in adults with hypertension or pre-diabetes.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take MegaNatural-BP SR 150Mg Tablet
  • 2.Take Placebo Capsule

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug routes

oral

Endpoints

Primary: Difference in change of diastolic blood pressure, Difference in change of systolic blood pressure

Secondary: Change in inflammatory marker C-reactive protein

Body systems

Cardiology / Heart